Krsnaa Diagnostics

Krsnaa Diagnostics Current Assets

The Current Assets of Krsnaa Diagnostics (KRSNAA.NS) as of Nov 7, 2026 is 4.43 B INR. In the previous year, Current Assets was 4.38 B INR — a change of 1.05% (higher).

Current Assets

4.43 BINR

YoY

1.05%

Last updated:

Current Assets of Krsnaa Diagnostics is 2026 4.43 B INR. Current Assets of Krsnaa Diagnostics was 2025 4.38 B INR. It decreases by 1.05% higher compared to the previous year.

The Krsnaa Diagnostics Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
1.89 B INR
Jan 1, 2020
1.99 B INR
Jan 1, 2021
2.41 B INR
Jan 1, 2022
3.26 B INR
Jan 1, 2023
2.20 B INR
Jan 1, 2024
4.40 B INR
Jan 1, 2025
4.38 B INR
Jan 1, 2026
4.43 B INR
The Krsnaa Diagnostics Current Assets history
YEARCurrent AssetsYoY
4.43 BINR+1.05%
4.38 BINR-0.47%
4.40 BINR+100.07%
2.20 BINR-32.50%
3.26 BINR+35.31%
2.41 BINR+21.13%
1.99 BINR+5.49%
1.89 BINR+1,119.83%
154.58 MINR+0.37%
154.01 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Krsnaa Diagnostics Stock analysis

What does Krsnaa Diagnostics do? Krsnaa Diagnostics Ltd provides diagnostic services across India, including radiology and pathology through X-Ray, CT scan, MRI, mammography, and tele-reporting. The company offers lab services for blood and urine investigations, supported by technology that aids healthcare professionals in diagnosing medical conditions. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS). The firm serves public and private hospitals, medical colleges, and community health centers as its primary customers. The company generates revenue through diagnostic service fees charged to hospitals, medical colleges, and community health centers. These institutions purchase the diagnostic services for their patients, utilizing Krsnaa's imaging and lab capabilities. The health packages are also sold to these institutions for patient care programs, contributing to the company's revenue streams. Krsnaa Diagnostics Ltd's product portfolio focuses on medical imaging and laboratory testing, targeting healthcare providers and institutions. The primary segments served are public and private hospitals, medical colleges, and community health centers, which rely on the company's diagnostic solutions for patient diagnostics and treatment planning. Krsnaa Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Krsnaa Diagnostics stock

Current Assets of Krsnaa Diagnostics is 4.43 B INR in 2026.

Current Assets of Krsnaa Diagnostics changed from 4.38 B INR to 4.43 B INR, representing a 1.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Krsnaa Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Krsnaa Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Krsnaa Diagnostics

All Key Metrics — Krsnaa Diagnostics